Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Inds is currently trading at Rs 731.40, up by 11.85 points or 1.65% from its previous closing of Rs 719.55 on the BSE.

The scrip opened at Rs 725.55 and has touched a high and low of Rs 733.75 and Rs 725.20 respectively. So far 3989 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 736.00 on 11-Dec-2012 and a 52 week low of Rs 488.25 on 02-Jan-2012.

Last one week high and low of the scrip stood at Rs 736.00 and Rs 706.00 respectively. The current market cap of the company is Rs 74976.13 crore.

The promoters holding in the company stood at 63.69% while Institutions and Non-Institutions held 25.63% and 10.69% respectively.

Sun Pharmaceutical Industries’ - wholly-owned subsidiary - Caraco Pharmaceutical Laboratories (Caraco), has entered into a definitive agreement with Takeda Pharmaceuticals USA, Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc’s generic business.

Upon completion of the purchase, the non-Colcrys (colchicine, USP) generic assets of URL Pharma will be owned and managed by Caraco.  The deal is however subject to satisfaction of customary closing conditions, including applicable regulatory approvals.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.